Search results
Positive results from a clinical trial
- Anavex Life Sciences (NASDAQ: AVXL) stock is rocketing higher on Friday following positive results from a clinical trial. The results come from its Phase 2b/3 clinical trial of ANAVEX®2-73. This is a treatment in development for Alzheimer’s disease.
investorplace.com › 2022 › 12
People also ask
Why is ANAVEX life sciences (avxl) stock rocketing higher?
Should you buy ANAVEX life sciences (avxl)?
Is ANAVEX stock moving higher Monday?
Why is ANAVEX life sciences (Avex) a good stock to buy?
Dec 2, 2022 · Anavex Life Sciences (NASDAQ: AVXL) stock is rocketing higher on Friday following positive results from a clinical trial. The results come from its Phase 2b/3 clinical trial of...
Jan 24, 2024 · Story continues. Anavex Life Sciences (AVXL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the...
- What Happened
- So What
- Now What
Shares of Anavex Life Sciences (AVXL5.01%)got a serious boost on Monday. Two of the company's leading pipeline drugs were positively highlighted in peer-reviewed research that was newly published in a medical journal, and the shares rose to close the day over 35% higher.
Late last week, the medical journal of Expert Opinion on Therapeutic Targetspublished research stating that two of Anavex's treatments for several afflictions related to the central nervous system, such as Alzheimer's, could be very effective in one aspect of fighting such diseases. The authors wrote that the expression of one type of receptor (a p...
ANAVEX2-73 has done well in clinical testing. In December, the company reported that a phase 2 trialshowed that it relieved symptoms in adult female patients afflicted with the rare genetic disease Rett syndrome, and was proved safe. This latest research adds to the positive momentum of both that drug and ANAVEX3-71.
Dec 17, 2022 · Wall Street analysts' average one-year price target on the stock, for example, is around $41 -- around 390% higher than its Thursday closing price of $8.35. With expected growth like that, the...
Jan 24, 2024 · January 24, 2024 — 12:00 pm EST. Written by Zacks Equity Research for Zacks -> Investors might want to bet on Anavex Life Sciences (AVXL), as it has been recently upgraded to a Zacks Rank #1...
Fiscal Q1 2024 ended 12/31/23. Reported on 2/7/24. Get the latest Anavex Life Sciences Corp (AVXL) real-time quote, historical performance, charts, and other financial information to help you...
Nov 20, 2023 · Benzinga. Nov. 20, 2023, 09:08 AM. Anavex Life Sciences Corp (NASDAQ:AVXL) shares are trading higher Monday. The clinical-stage biopharmaceutical company announced that it initiated a...